60mg vial of tirzepatide BPI Labs Tirzepatide Munjaro 60mg x1 vial
Description
For the risk of addon therapy, the magnitude but not the direction changed in subgroups of sex, age, cardiovascular disease (CVD), and hypertension
Short-Term Effects (Usually Mild and Temporary): Redness
Effectiveness and Safety Profiles These medications can be highly effective, but they are not magic pills
Nutrients, 12(1), p.157
